Navigation Links
Patients With Filariasis More Prone To HIV Infection

According to a report published in the December issue of the Journal of Infectious Diseases, HIV infection is significantly enhanced in peripheral blood mononuclear cells (PBMCs) from individuals with untreated filarial infection compared to PBMCs from infected patients treated with antifilarial agents. According to Dr. Ramya Gopinath and her team at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, ‘Studies suggest that immune activation resulting from the high prevalence of helminth infection in the developing world may contribute to rapid spread and progression of HIV infection in these areas’. The study found increased HIV replication in peripheral blood mononuclear cells from filarial infected patients. Conversely, there was a striking and significant decrease in HIV replication in PBMCs isolated from patients treated with antifilarials compared with those from untreated individuals particularly with respect to replication of M tropic HIV. This report should ring alarm bells in the third world countries and in regions where HIV and Filaria are both rampan.
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Glivec - New Hope For CMC Patients
5. Patients often assume wrongly that they are allergic to penicillin
6. New FDA Approved Drug NATRECOR For Heart Failure Patients
7. Hemochromatosis Patients Blood is Safe
8. Patients Pressure Would Result In Overprescription
9. Risk Of Decongestants In Hypertensive Patients
10. Interference helps Heart Patients
11. Stem Cell Transplants May Be Effective For MS Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... Loyale Healthcare ... Growth. Mr. Smith joins other recent high-profile hires including Frank Massi, Chief Revenue ... began in 1993, helping physician practices and hospitals automate their clinical and financial ...
(Date:8/23/2017)... ... 23, 2017 , ... CEFEX, the Centre for Fiduciary Excellence, ... representing best practices in the retirement plan industry. The independent CEFEX Investment Advisor ... verify that NFP’s retirement division focuses on putting clients’ interests first and acting ...
(Date:8/23/2017)... ... August 23, 2017 , ... Cirrus Medical Staffing, ... new website, http://www.cirrusmedicalstaffing.com . The new site pairs a robust job search ... professionals who are traveling on short-term assignments to healthcare facilities around the country. ...
(Date:8/23/2017)... CA (PRWEB) , ... August 23, 2017 , ... Silicon ... to announce a new blog archive organized month-by-month. The new rotation of archived blog ... Local Bay Area residents searching information about hair transplantation can review details online and ...
(Date:8/23/2017)... ... 2017 , ... The non-profit Seafood Nutrition Partnership (SNP) ... the Science Symposium in partnership with the Global Organization for EPA and DHA ... a forum for global leaders in human nutrition to outline the latest consensus ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... and Gulf Coast Regional Blood Center to host a blood ... Law family has had 3 members that needed blood products ... is partnering with Gulf Coast Regional Blood Center of ... supplies are running low. Gulf Coast Regional Blood Center,s inventory is ... is why the blood center reached out to Mostyn Law ...
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
Breaking Medicine Technology: